CIBC Private Wealth Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $14.5M | Sell |
268,354
-10,873
| -4% | -$523K | 0.02% | 311 |
|
|
2025
Q3 | $12.6M | Sell |
279,227
-5,525
| -2% | -$258K | 0.02% | 320 |
|
|
2025
Q2 | $13.2M | Sell |
284,752
-12,332
| -4% | -$605K | 0.02% | 320 |
|
|
2025
Q1 | $15.8M | Sell |
297,084
-10,498
| -3% | -$612K | 0.03% | 278 |
|
|
2024
Q4 | $17.5M | Buy |
307,582
+11,057
| +4% | +$618K | 0.03% | 287 |
|
|
2024
Q3 | $15.3M | Buy |
296,525
+97,758
| +49% | +$4.59M | 0.03% | 301 |
|
|
2024
Q2 | $7.95M | Sell |
198,767
-13,073
| -6% | -$585K | 0.01% | 348 |
|
|
2024
Q1 | $11.2M | Buy |
211,840
+5,435
| +3% | +$277K | 0.02% | 314 |
|
|
2023
Q4 | $10.6M | Sell |
206,405
-8,052
| -4% | -$423K | 0.02% | 309 |
|
|
2023
Q3 | $12.4M | Sell |
214,457
-76,350
| -26% | -$4.68M | 0.03% | 297 |
|
|
2023
Q2 | $18.6M | Sell |
290,807
-39,898
| -12% | -$2.68M | 0.04% | 273 |
|
|
2023
Q1 | $22.9M | Sell |
330,705
-14,284
| -4% | -$1.01M | 0.05% | 231 |
|
|
2022
Q4 | $18.8M | Sell |
344,989
-74,525
| -18% | -$5.62M | 0.06% | 194 |
|
|
2022
Q3 | $29.8M | Sell |
419,514
-10,127
| -2% | -$735K | 0.08% | 179 |
|
|
2022
Q2 | $33.1M | Sell |
429,641
-12,743
| -3% | -$971K | 0.09% | 175 |
|
|
2022
Q1 | $32.3M | Buy |
442,384
+9,042
| +2% | +$607K | 0.07% | 193 |
|
|
2021
Q4 | $27M | Buy |
433,342
+12,270
| +3% | +$720K | 0.06% | 224 |
|
|
2021
Q3 | $24.9M | Sell |
421,072
-23,978
| -5% | -$1.58M | 0.06% | 217 |
|
|
2021
Q2 | $29.7M | Sell |
445,050
-28,981
| -6% | -$1.89M | 0.07% | 201 |
|
|
2021
Q1 | $29.9M | Sell |
474,031
-7,466
| -2% | -$465K | 0.08% | 190 |
|
|
2020
Q4 | $29.9M | Buy |
481,497
+62,415
| +15% | +$3.84M | 0.08% | 183 |
|
|
2020
Q3 | $25.2M | Buy |
419,082
+114,471
| +38% | +$6.89M | 0.08% | 176 |
|
|
2020
Q2 | $17.9M | Sell |
304,611
-21,738
| -7% | -$1.3M | 0.09% | 154 |
|
|
2020
Q1 | $18.2M | Buy |
326,349
+7,816
| +2% | +$478K | 0.08% | 179 |
|
|
2019
Q4 | $20.4M | Buy |
318,533
+104,109
| +49% | +$5.96M | 0.07% | 202 |
|
|
2019
Q3 | $10.9M | Sell |
214,424
-20,832
| -9% | -$979K | 0.04% | 267 |
|
|
2019
Q2 | $10.7M | Sell |
235,256
-15,861
| -6% | -$739K | 0.04% | 274 |
|
|
2019
Q1 | $12M | Sell |
251,117
-60,796
| -19% | -$3.03M | 0.05% | 260 |
|
|
2018
Q4 | $16.2M | Sell |
311,913
-38,161
| -11% | -$2.05M | 0.07% | 208 |
|
|
2018
Q3 | $21.7M | Sell |
350,074
-12,943
| -4% | -$768K | 0.08% | 202 |
|
|
2018
Q2 | $20.1M | Sell |
363,017
-18,037
| -5% | -$974K | 0.08% | 205 |
|
|
2018
Q1 | $24.1M | Sell |
381,054
-23,045
| -6% | -$1.48M | 0.1% | 186 |
|
|
2017
Q4 | $24.8M | Sell |
404,099
-8,561
| -2% | -$535K | 0.11% | 182 |
|
|
2017
Q3 | $26.3M | Buy |
412,660
+103,357
| +33% | +$6.03M | 0.12% | 167 |
|
|
2017
Q2 | $17.2M | Sell |
309,303
-27,915
| -8% | -$1.52M | 0.11% | 152 |
|
|
2017
Q1 | $18.3M | Sell |
337,218
-52,305
| -13% | -$2.87M | 0.12% | 141 |
|
|
2016
Q4 | $22.8M | Sell |
389,523
-26,955
| -6% | -$1.47M | 0.15% | 124 |
|
|
2016
Q3 | $22.5M | Sell |
416,478
-12,612
| -3% | -$810K | 0.16% | 123 |
|
|
2016
Q2 | $31.6M | Sell |
429,090
-2,888
| -0.7% | -$204K | 0.23% | 103 |
|
|
2016
Q1 | $27.6M | Sell |
431,978
-22,152
| -5% | -$1.4M | 0.21% | 103 |
|
|
2015
Q4 | $31.2M | Buy |
454,130
+213,573
| +89% | +$14.1M | 0.24% | 101 |
|
|
2015
Q3 | $14.2M | Buy |
240,557
+805
| +0.3% | +$51.1K | 0.12% | 147 |
|
|
2015
Q2 | $16M | Buy |
239,752
+7,430
| +3% | +$490K | 0.12% | 148 |
|
|
2015
Q1 | $15M | Buy |
232,322
+418
| +0.2% | +$26.2K | 0.11% | 155 |
|
|
2014
Q4 | $13.7M | Sell |
231,904
-6,956
| -3% | -$392K | 0.1% | 154 |
|
|
2014
Q3 | $12.2M | Sell |
238,860
-5,986
| -2% | -$299K | 0.1% | 169 |
|
|
2014
Q2 | $11.9M | Sell |
244,846
-54,174
| -18% | -$2.67M | 0.1% | 171 |
|
|
2014
Q1 | $15.4M | Buy |
+299,020
| New | +$15.9M | 0.13% | 141 |
|
Other funds holding BMY
CIBC Private Wealth Group's BMY Position: Q4 2025 in Review
CIBC Private Wealth Group reduced its Bristol-Myers Squibb (BMY) stake by 3.9% in Q4 2025, selling an estimated $523K and leaving 268,354 shares worth $14.5M. The position accounts for 0.02% of the portfolio, ranked #311.
CIBC Private Wealth Group first reported a position in BMY in Q1 2014 and has held it in 48 quarters since. The position peaked at $33.1M in Q2 2022. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- CIBC Private Wealth Group held 268,354 shares of Bristol-Myers Squibb worth $14.5M as of Q4 2025.
- CIBC Private Wealth Group sold 10,873 Bristol-Myers Squibb shares in Q4 2025, an estimated $523K.
- Bristol-Myers Squibb made up 0.02% of CIBC Private Wealth Group's portfolio in Q4 2025, its #311 holding.
- CIBC Private Wealth Group first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 48 quarters since.
- CIBC Private Wealth Group's Bristol-Myers Squibb position peaked at $33.1M in Q2 2022.
- 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.